XCSE
SPG
Market cap771mUSD
Jun 18, Last price
428.00DKK
1D
0.94%
1Q
22.64%
Jan 2017
217.51%
Name
SP Group A/S
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
SP Group A/S, operating through its subsidiaries, specializes in the production and global distribution of molded plastic and composite components. Its extensive reach encompasses clients across Denmark, the broader European continent, the Americas, Asia, the Middle East, Australia, and Africa. The company's core activities include the innovation and manufacturing of fluoroplastic coatings, PTFE, and other advanced materials, predominantly for the healthcare, cleantech, and food-processing industries. Additionally, they produce a diverse array of polyurethane items—including solid, foamed, flexible, and light-foam variations—specifically designed for the cleantech sector, alongside general ventilation equipment, ergonomic mats, and striping products. SP Group A/S also delivers thermo-formed plastic components, which find applications in refrigerators, freezers, various automotive and transportation vehicles (cars, buses, rolling stock), and within the cleantech and medical device fields. Their services further extend to crafting injection-molded plastic precision components for a wide range of industries, supplying packaging for FDA-registered products crucial to the medical device industry, and providing rotational-molded precision components for numerous applications. Other specialized offerings include fenders and buoys for the maritime industry, blow-molded plastic precision components for medical devices, and sophisticated composite solutions leveraging various raw materials. Beyond manufacturing, the company performs specialized coatings on both plastic and metal components and maintains advanced 3D printing and machining capabilities. SP Group A/S was founded in 1962 and is headquartered in Søndersø, Denmark.
Valuation
Title DKK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||